Aprea Therapeutics Total Risk Alpha

APRE Stock  USD 0.76  0.03  4.11%   
The Total Risk Alpha reading for Aprea Therapeutics is computed from historical trading observations. Extended technical indicator views are accessible through Equity Screeners. Aprea Therapeutics has a market cap of 8.73 M, operating margin of -792.06%, ROE of -74.72%. See Trending Equities for portfolio-level analysis. This includes a position in Aprea Therapeutics. Each holding is sized according to the methodology applied to the portfolio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Our How to Trade Aprea Therapeutics guide. The guide covers key considerations before placing your first order for Aprea Stock. Review it before making any investment decisions about Aprea Therapeutics.
Aprea Therapeutics has current Total Risk Alpha of 0.8683. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
0.8683
ER[a] = Expected return on investing in Aprea Therapeutics
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on Aprea Therapeutics
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Total Risk Alpha Peers Comparison

Total Risk Alpha Relative To Other Indicators

Aprea Therapeutics holds the #5 position for total risk alpha relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers with a Maximum Drawdown-to-Total Risk Alpha ratio near 53.28 . The Maximum Drawdown to Total Risk Alpha ratio for Aprea Therapeutics comes in at 53.28
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund. Compare Aprea Therapeutics to Peers

Other Technical Indicators